Large-scale testing (Phase 3)Study completedNCT01626378
What this trial is testing
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Who this might be right for
Behavioral Variant Frontotemporal Dementia (bvFTD)
TauRx Therapeutics Ltd 220